Bong Soo Kim
Papers
1
Total Citations
2
H-Index
1
About
Dr. Bong Soo Kim is a pioneering researcher at the intersection of oncology, endocrinology, and microbiology, whose work is reshaping our understanding of how systemic diseases influence cancer biology. His primary research focus lies in the prostate tumor microenvironment, with a particular emphasis on the role of the tissue-resident microbiome in prostate cancer progression. Dr. Kim’s most notable contribution, detailed in his 2024 study on the influence of diabetes on the prostate microbiome, addresses a critical gap in the field. By demonstrating that metabolic conditions like diabetes can significantly alter the bacterial composition within prostate tissues, his work provides a novel framework for understanding how comorbidities may drive cancer aggressiveness and treatment resistance. This study, already garnering 2 citations in its first year, is gaining traction for its methodological rigor in tackling the pervasive issue of sample contamination that has plagued prior microbiome research. Dr. Kim’s findings have profound implications for personalized medicine, suggesting that a patient’s metabolic health could be a key variable in predicting prostate cancer outcomes. For students and researchers, his work exemplifies the power of interdisciplinary investigation, bridging endocrinology and tumor biology to uncover hidden drivers of disease.
Research Focus
Key Achievements
Top Papers
- 1